Clinical usability of the Story-Based Empathy Task (SET) in non-demented ALS patients.

Amyotrophic lateral sclerosis Frontotemporal degeneration Neuropsychology Social cognition Story-Based Empathy Task

Journal

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 25 02 2023
accepted: 31 03 2023
medline: 11 8 2023
pubmed: 6 4 2023
entrez: 5 4 2023
Statut: ppublish

Résumé

This study aimed at assessing the clinical usability of the Story-Based Empathy Task (SET) in non-demented amyotrophic lateral sclerosis (ALS) patients. N = 106 non-demented ALS patients and N = 101 healthy controls (HCs) were administered the SET, which includes three subtests assessing Emotion Attribution (SET-EA), Intention Attribution (SET-IA) and causal inference (SET-CI) - the latter being a control task. Patients also underwent the Reading the Mind in the Eyes Test (RMET), the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) and a thorough behavioural and motor-functional evaluation. The diagnostics of the SET-EA and -IA were tested against a defective performance on the RMET. The association between SET subtests and cognitive/behavioural outcomes was examined net of demographic and motor-functional confounders. Case-control discrimination was explored for each SET subtest. Demographically adjusted SET-EA and -IA scores accurately detected defective RMET performances at the optimal cutoffs of <3.04 (AUC = .84) and <3.61 (AUC = .88), respectively. By contrast, the SET-CI performed poorly in doing so (AUC = .58). The SET-EA converged with the RMET, as well as with ECAS-Executive and -Memory scores, whilst the SET-IA was unrelated to cognitive measures (including the RMET); the SET-CI was related to the ECAS-Language the ECAS-Executive. SET subscores were unrelated to behavioural outcomes. Only the SET-EA discriminated patients from HCs. The SET as a whole should not be addressed as a social-cognitive measure in this population. At variance, its subtest tapping on emotional processing - i.e., the SET-EA - is recommended for use as an estimate of social-cognitive abilities in non-demented ALS patients.

Sections du résumé

BACKGROUND BACKGROUND
This study aimed at assessing the clinical usability of the Story-Based Empathy Task (SET) in non-demented amyotrophic lateral sclerosis (ALS) patients.
METHODS METHODS
N = 106 non-demented ALS patients and N = 101 healthy controls (HCs) were administered the SET, which includes three subtests assessing Emotion Attribution (SET-EA), Intention Attribution (SET-IA) and causal inference (SET-CI) - the latter being a control task. Patients also underwent the Reading the Mind in the Eyes Test (RMET), the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) and a thorough behavioural and motor-functional evaluation. The diagnostics of the SET-EA and -IA were tested against a defective performance on the RMET. The association between SET subtests and cognitive/behavioural outcomes was examined net of demographic and motor-functional confounders. Case-control discrimination was explored for each SET subtest.
RESULTS RESULTS
Demographically adjusted SET-EA and -IA scores accurately detected defective RMET performances at the optimal cutoffs of <3.04 (AUC = .84) and <3.61 (AUC = .88), respectively. By contrast, the SET-CI performed poorly in doing so (AUC = .58). The SET-EA converged with the RMET, as well as with ECAS-Executive and -Memory scores, whilst the SET-IA was unrelated to cognitive measures (including the RMET); the SET-CI was related to the ECAS-Language the ECAS-Executive. SET subscores were unrelated to behavioural outcomes. Only the SET-EA discriminated patients from HCs.
CONCLUSIONS CONCLUSIONS
The SET as a whole should not be addressed as a social-cognitive measure in this population. At variance, its subtest tapping on emotional processing - i.e., the SET-EA - is recommended for use as an estimate of social-cognitive abilities in non-demented ALS patients.

Identifiants

pubmed: 37017748
doi: 10.1007/s10072-023-06791-z
pii: 10.1007/s10072-023-06791-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3181-3187

Informations de copyright

© 2023. Fondazione Società Italiana di Neurologia.

Références

Dodich A, Cerami C, Canessa N, Crespi C, Iannaccone S, Marcone A, Cappa SF (2015) A novel task assessing intention and emotion attribution: Italian standardization and normative data of the Story-based Empathy Task. Neurol Sci 36:1907–1912
doi: 10.1007/s10072-015-2281-3 pubmed: 26072203
Cerami C, Dodich A, Canessa N, Crespi C, Iannaccone S, Corbo M, Cappa SF (2014) Emotional empathy in amyotrophic lateral sclerosis: a behavioural and voxel-based morphometry study. Amyotroph Lateral Scler Frontotemporal Degener 15:21–29
doi: 10.3109/21678421.2013.785568 pubmed: 23586919
Crespi C, Cerami C, Dodich A, Canessa N, Iannaccone S, Corbo M, Cappa SF (2016) Microstructural correlates of emotional attribution impairment in non-demented patients with amyotrophic lateral sclerosis. PLoS One 11:e0161034
doi: 10.1371/journal.pone.0161034 pubmed: 27513746 pmcid: 4981464
Palumbo F, Iazzolino B, Peotta L, Canosa A, Manera U, Grassano M, Calvo A (2022) Social cognition deficits in amyotrophic lateral sclerosis: a pilot cross-sectional population-based study. Eur J Neurol 29:2211–2219
doi: 10.1111/ene.15388 pubmed: 35524505 pmcid: 9541579
Aiello EN, Carelli L, Solca F, Torre S, Ferrucci R, Priori A, Poletti B (2022) Validity and diagnostics of the Reading the Mind in the Eyes Test (RMET) in non-demented amyotrophic lateral sclerosis (ALS) patients. Front Psychol 13:1–8
doi: 10.3389/fpsyg.2022.1031841
Bora E (2017) Meta-analysis of social cognition in amyotrophic lateral sclerosis. Cortex 88:1–7
doi: 10.1016/j.cortex.2016.11.012 pubmed: 28002755
Carelli L, Solca F, Tagini S, Torre S, Verde F, Ticozzi N, Silani V (2021) Emotional processing and experience in amyotrophic lateral sclerosis: a systematic and critical review. Brain Sci 11:1356
doi: 10.3390/brainsci11101356 pubmed: 34679420 pmcid: 8534224
Strong MJ, Abrahams S, Goldstein LH, Woolley S, Mclaughlin P, Snowden J, Turner MR (2017) Amyotrophic lateral sclerosis-frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener 18:153–174
doi: 10.1080/21678421.2016.1267768 pubmed: 28054827 pmcid: 7409990
Watermeyer TJ, Brown RG, Sidle KC, Oliver DJ, Allen C, Karlsson J, Goldstein LH (2015) Executive dysfunction predicts social cognition impairment in amyotrophic lateral sclerosis. J Neurol 262:1681–1690
doi: 10.1007/s00415-015-7761-0 pubmed: 25957636
van der Hulst EJ, Bak TH, Abrahams S (2015) Impaired affective and cognitive theory of mind and behavioural change in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 86:1208–1215
doi: 10.1136/jnnp-2014-309290
Brooks BR, Miller RG, Swash M, Munsat TL (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293–299
doi: 10.1080/146608200300079536 pubmed: 11464847
Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, Grossman M (2011) Classification of primary progressive aphasia and its variants. Neurology 76:1006–1014
doi: 10.1212/WNL.0b013e31821103e6 pubmed: 21325651 pmcid: 3059138
Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, Miller BL (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 13:2456–2477
doi: 10.1093/brain/awr179
Maddaluno O, Aiello EN, Roncoroni C, Prunas A, Bolognini N (2022) The Reading the mind in the eyes test, Iowa gambling task and interpersonal reactivity index: normative data in an Italian population sample. Arch Clin Neuropsychol 37:929–938
doi: 10.1093/arclin/acab100 pubmed: 35107132
Poletti B, Solca F, Carelli L, Madotto F, Lafronza A, Faini A, Silani V (2016) The validation of the Italian Edinburgh cognitive and behavioural ALS screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener 17:489–498
doi: 10.1080/21678421.2016.1183679 pubmed: 27219526
Spielberger CD, Gonzalez-Reigosa F, Martinez-Urrutia A, Natalicio LF, Natalicio DS (1971) The state-trait anxiety inventory. Interam J Psychol 5:145–158
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571
doi: 10.1001/archpsyc.1961.01710120031004 pubmed: 13688369
Iazzolino B, Pain D, Laura P, Aiello EN, Gallucci M, Radici A, Chiò A (2022) Italian adaptation of the Beaumont Behavioral Inventory (BBI): psychometric properties and clinical usability. Amyotroph Lateral Scler Frontotemporal Degener 23:81–86
doi: 10.1080/21678421.2021.1946085 pubmed: 34279169
Santangelo G, Raimo S, Siciliano M, D’Iorio A, Piscopo F, Cuoco S, Trojano L (2017) Assessment of apathy independent of physical disability: validation of the Dimensional Apathy Scale in Italian healthy sample. Neurol Sci 38:303–309
doi: 10.1007/s10072-016-2766-8 pubmed: 27844173
Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, BDNF Study Group (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 169:13–21
doi: 10.1016/S0022-510X(99)00210-5 pubmed: 10540002
Kimura F, Fujimura C, Ishida S, Nakajima H, Furutama D, Uehara H, Hanafusa T (2006) Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 66:265–267
doi: 10.1212/01.wnl.0000194316.91908.8a pubmed: 16434671
Roche JC, Rojas-Garcia R, Scott KM, Scotton W, Ellis CE, Burman R, Al-Chalabi A (2012) A proposed staging system for amyotrophic lateral sclerosis. Brain 135:847–852
doi: 10.1093/brain/awr351 pubmed: 22271664 pmcid: 3286327
Chiò A, Hammond ER, Mora G, Bonito V, Filippini G (2015) Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 86:38–44
doi: 10.1136/jnnp-2013-306589 pubmed: 24336810
Taule T, Søvik M, Lein RK, Wehling E, Aßmus J, Rekand T (2020) Psychometric properties of cognitive assessment in amyotrophic lateral sclerosis: a systematic review. Patient Relat Outcome Meas:181–194
Kim HY (2013) Statistical notes for clinical researchers: assessing normal distribution (2) using skewness and kurtosis. Restor Dent Endod 38:52–54
doi: 10.5395/rde.2013.38.1.52 pubmed: 23495371 pmcid: 3591587
Consonni M, Catricala E, Dalla Bella E, Gessa VC, Lauria G, Cappa SF (2016) Beyond the consensus criteria: multiple cognitive profiles in amyotrophic lateral sclerosis? Cortex 81:162–167
doi: 10.1016/j.cortex.2016.04.014 pubmed: 27236371
Spreng RN, Mar RA (2012) I remember you: a role for memory in social cognition and the functional neuroanatomy of their interaction. Brain Res 1428:43–50
doi: 10.1016/j.brainres.2010.12.024 pubmed: 21172325
Dodich A, Crespi C, Santi GC, Luzzi S, Ranaldi V, Iannaccone S, Cerami C (2021) Diagnostic accuracy of affective social tasks in the clinical classification between the behavioral variant of frontotemporal dementia and other neurodegenerative disease. J Alzheimers Dis 80:1401–1411
doi: 10.3233/JAD-201210 pubmed: 33682708
Poletti B, Solca F, Carelli L, Faini A, Madotto F, Lafronza A, Silani V (2018) Cognitive-behavioral longitudinal assessment in ALS: the Italian Edinburgh Cognitive and Behavioral ALS screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener 19:387–395
doi: 10.1080/21678421.2018.1473443 pubmed: 29804470
Aiello EN, Solca F, Torre S, Carelli L, Monti A, Ferrucci R, Poletti B (2022) Reliable change indices for the Italian Edinburgh Cognitive and Behavioral ALS Screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener:1–4
Poletti B, Carelli L, Solca F, Lafronza A, Pedroli E, Faini A, Silani V (2017) An eye-tracker controlled cognitive battery: overcoming verbal-motor limitations in ALS. J Neurol 264:1136–1145
doi: 10.1007/s00415-017-8506-z pubmed: 28503706
Cipresso P, Meriggi P, Carelli L, Solca F, Meazzi D, Poletti B, Silani V (2011) The combined use of Brain Computer Interface and Eye-Tracking technology for cognitive assessment in Amyotrophic Lateral Sclerosis. In: In 2011 5th International conference on pervasive computing technologies for healthcare (PervasiveHealth) and workshops. IEEE, pp 320–324

Auteurs

Edoardo Nicolò Aiello (EN)

Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, 20149, Milano, Italy.

Federica Solca (F)

Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, 20149, Milano, Italy.

Silvia Torre (S)

Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, 20149, Milano, Italy.

Eleonora Colombo (E)

Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, 20149, Milano, Italy.

Alessio Maranzano (A)

Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, 20149, Milano, Italy.

Marco Olivero (M)

Neurology Residency Program, Università degli Studi di Milano, Milano, Italy.

Francesco Scheveger (F)

Neurology Residency Program, Università degli Studi di Milano, Milano, Italy.

Claudia Morelli (C)

Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, 20149, Milano, Italy.

Alberto Doretti (A)

Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, 20149, Milano, Italy.

Federico Verde (F)

Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, 20149, Milano, Italy.
Department of Pathophysiology and Transplantation, "Dino Ferrari" Center, Università degli Studi di Milano, Milano, Italy.

Roberta Ferrucci (R)

Department of Oncology and Hemato-Oncology, University of Milan, Milano, Italy.
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.

Sergio Barbieri (S)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.

Francesca Mameli (F)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.

Alberto Priori (A)

Aldo Ravelli Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, International Medical School, University of Milan, Milano, Italy.
ASST Santi Paolo e Carlo, San Paolo University Hospital, Milano, Italy.

Vincenzo Silani (V)

Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, 20149, Milano, Italy.
Department of Pathophysiology and Transplantation, "Dino Ferrari" Center, Università degli Studi di Milano, Milano, Italy.

Nicola Ticozzi (N)

Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, 20149, Milano, Italy.
Department of Pathophysiology and Transplantation, "Dino Ferrari" Center, Università degli Studi di Milano, Milano, Italy.

Barbara Poletti (B)

Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, 20149, Milano, Italy. b.poletti@auxologico.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH